A2 Milk infant formula could soon get approval to be sold in the US.
The post Here’s why the A2 Milk share price just popped then stopped appeared first on The Motley Fool Australia. –
The company’s shares are frozen at $4.85 apiece — that’s 6.83% above yesterday’s closing price.
There is currently an infant formula shortage in the US after a reported potential contamination at one of the nation’s largest manufacturing plants that produces formula.
Since then, several international producers have swung into action to provide as much product to the US as possible, including Bubs Australia Ltd (ASX: BUB).
However, this relies on the US Food and Drug Administration (FDA) giving product approvals through relaxed importing rules. The US government has also provided planes to transport infant formula into the country.
Good news for A2 Milk shares?
According to reporting by the Australian Financial Review, A2 Milk may get the necessary clearance âas soon as this weekâ for its application to sell infant formula in the country.
The newspaper reported A2 Milk CEO David Bortolussi said:
We have been informed that our application is under active review, and we hope to be able to support US parents and caregivers during this difficult period.
While A2 Milk doesnât currently have approval to sell infant formula in the US, it does sell fresh milk into the country.
In its FY22 half-year result, A2 Milk reported that its US segment revenue decreased 5.2% to $32.4 million and earnings before interest, tax, depreciation and amortisation (EBITDA) dropped 41.5%, resulting in a loss of $16.4 million.
However, A2 Milk isnât alone in awaiting FDA approval to sell its formula products in the US. According to the AFRâs reporting, around 160 companies have applied for FDA approval.
With a population well north of 300 million, the US represents a large potential market for infant formula producers, which is why Bubs, A2 Milk, and many others want a piece of that opportunity.
What will this mean for the company?
For Bubs, it has led to a number of promising developments. Bubs is steadily sending a total of 1.25 million tins of infant formula to the US and has announced a number of supplier agreements with US retailers such as Target and Walmart.
The FDA is also developing a new framework to allow companies with current approval to have a pathway to continue supplying the market beyond November.
So, will A2 Milk manage to get a deal for at least one million tins? How many retailers will A2 Milk be able to work with? Can it fast-track the logistics by signing deals with retailers itâs already selling milk to?
Time will reveal if A2 Milk gets approval then what itâs able to do with it.
Investors seem to be betting on a good outcome.
While the A2 Milk share price has jumped higher today, itâs still 11% lower than it was at the start of 2022.
A2 Milk entered into a trading halt before making another announcement. The company says the trading halt will stay in place until 4 August 2022, or until an announcement has been made.
The post Here’s why the A2 Milk share price just popped then stopped appeared first on The Motley Fool Australia.
Before you consider A2 Milk Company Ltd, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and A2 Milk Company Ltd wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
See The 5 Stocks
*Returns as of July 7 2022
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
Why A2 Milk, Qualitas, Telix, and Ventia shares are pushing higher today
Own A2 Milk shares? Here’s what to expect from its FY22 results
The A2 Milk share price has bubbled 10% higher in a month. What’s going on?
Here’s why the A2 Milk share price crashed 27% lower in FY22
Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.